Mar Reyes

Senior Director, Data Management at QED Therapeutics - Palo Alto, CA, US

Mar Reyes's Colleagues at QED Therapeutics
Lihua Zhang

Director, Pharmaceutical Development

Contact Lihua Zhang

Brian Eater

Director Of Quality Assurance

Contact Brian Eater

Yen Nguyen

Senior Executive Administrator

Contact Yen Nguyen

Ray Villar

CMC Technical Writer

Contact Ray Villar

View All Mar Reyes's Colleagues
Mar Reyes's Contact Details
HQ
650-231-4088
Location
Company
QED Therapeutics
Mar Reyes's Company Details
QED Therapeutics logo, QED Therapeutics contact details

QED Therapeutics

Palo Alto, CA, US • 100 - 249 Employees
BioTech/Drugs

QED Therapeutics, a subsidiary of BridgeBio Pharma, is a biotechnology company focused on precision medicine for FGFR-driven disorders. Our lead candidate is infigratinib, a best-in-class FGFR kinase inhibitor that has shown meaningful clinical activity in chemotherapy-refractory cholangiocarcinoma with FGFR2 fusions. QED is also evaluating infigratinib in preclinical studies for the treatment of achondroplasia. We plan to develop infigratinib in additional FGFR-driven tumor types and rare disorders.

N/A
Details about QED Therapeutics
Frequently Asked Questions about Mar Reyes
Mar Reyes currently works for QED Therapeutics.
Mar Reyes's role at QED Therapeutics is Senior Director, Data Management.
Mar Reyes's email address is ***@qedtx.com. To view Mar Reyes's full email address, please signup to ConnectPlex.
Mar Reyes works in the Biotechnology industry.
Mar Reyes's colleagues at QED Therapeutics are Lihua Zhang, Brian Eater, Yen Nguyen, Andrea Orozco, Adalynn Harris, Ray Villar, Kimberly Richards and others.
Mar Reyes's phone number is 650-231-4088
See more information about Mar Reyes